Gland Pharma stock analysis

Gland Pharma soars on getting EIR from USFDA for Visakhapatnam facility

by
Gland Pharma

Gland Pharma is currently trading at Rs. 1780.00, up by 36.20 points or 2.08% from its previous closing of Rs. 1743.80 on the BSE. The scrip opened at Rs. 1587.55 and has touched a high and low of Rs. 1800.00 and Rs. 1587.55 respectively. So far 3074 shares were traded on the counter. The BSE … Read more

Gland Pharma Gains as USFDA Completes Pre-Approval Inspection at Visakhapatnam Facility

by
Gland Pharma

Gland Pharma’s stock surged on the BSE, following the successful conclusion of a Pre-Approval Inspection (PAI) by the United States Food and Drug Administration (USFDA) at its Visakhapatnam facility. The stock is currently trading at ₹1,616.15, up by ₹20.65 or 1.29%, compared to its previous closing price of ₹1,595.50. Stock Performance Overview Opening Price: ₹1,604.85 … Read more

BREAKING NEWS:
► Rajasthan ATS Launches Action Against Suspected Cross-Border Network; Seven Arrested ► Remembering Revolutionary Sukadev: A Beacon of Freedom ► Assam Police Seize Drugs Worth ₹21.36 Crore, Five Arrested ► Sinner Advances to Italian Open Semifinals by Defeating Rublev ► Assam CM Reviews Power Projects to Strengthen Energy Infrastructure ► Rajasthan Aims for 43,000 PNG Connections in 45 Days ► Tamil Nadu CM Urges PM Modi to Remove Cotton Import Duty ► Political Tensions Rise Over Delayed Payments in Jammu and Kashmir ► Preparations for Kumbh Mela 2028 Underway in Ujjain ► Public Angry Over Power Cuts & Voltage Fluctuation in Udaipur
“Prateek Yadav dreams of owning a ₹5 crore ‘Blue Bolt'” Kia Sonet’s Second Generation: Enhanced Safety and Features! Will WhatsApp require a subscription? Discover the truth!